StockComparison Logo
vs

PRME vs DNA

Comparison between Prime Medicine Inc (PRME, Company) and Ginkgo Bioworks Holdings Inc - Class A (DNA, Company).

Both PRME and DNA are from the Healthcare sector.

PRME vs DNA - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
PRME
$489M
Winner
DNA
$490M
Max Drawdown
Winner
PRME
94.55%
DNA
99.10%
Sharpe Ratio
Winner
PRME
1.05
DNA
0.40
5Y Beta
Winner
PRME
2.13
DNA
2.38
Industry
PRME
Biotechnology
DNA
Biotechnology
P/E Ratio
Winner
PRME
-2.26
DNA
-1.52
Debt to Equity
PRME
0.00%
DNA
0.00%
Free Cash Flow Yield
Winner
PRME
-32.43%
DNA
-34.36%
P/S Ratio
PRME
121.34
Winner
DNA
3.32
P/B Ratio
PRME
6.38
Winner
DNA
1.17

PRME vs DNA - Historical Returns

Returns include dividend reinvestment.

1M
PRME
-15.91%
Winner
DNA
-5.34%
3M
PRME
-25.60%
Winner
DNA
+23.36%
6M
PRME
-32.32%
Winner
DNA
-15.47%
1Y
Winner
PRME
+90.07%
DNA
-15.02%
5Y(CAGR)
PRME
N/A
DNA
-54.38%
Max(CAGR)
Winner
PRME
-37.48%
DNA
-53.46%

PRME vs DNA - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

YearPRMEDNA
2026-21.39%-9.25%
2025+16.05%-18.69%
2024-66.67%-85.30%
2023-49.49%+6.96%
2022+20.88%-80.55%
2021N/A-17.89%

PRME vs DNA Drawdown Comparison

The maximum drawdown for PRME was -94.55%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The maximum drawdown for DNA was -99.10%, occurring on Sep 9, 2024. This drawdown has not yet recovered.

The current PRME drawdown is -86.86%. The current DNA drawdown is -98.68%.

RankPRMEDNA
#1-94.55%
Nov 1, 2022 - Apr 8, 2025
-99.10%
Nov 8, 2021 - Sep 9, 2024
#2-3.55%
Oct 21, 2022 - Oct 25, 2022
-28.69%
Sep 27, 2021 - Oct 19, 2021
#3N/A-11.76%
Apr 23, 2021 - Sep 16, 2021
#4N/A-11.28%
Oct 19, 2021 - Nov 8, 2021
#5N/A-8.78%
Sep 17, 2021 - Sep 23, 2021

Correlation

Correlation between PRME and DNA is 0.90 which considered as a strong positive correlation - the stocks tend to move together.

0.90
-101

Select Stocks to Compare